Unicycive Therapeutics, Inc. Common Stock

UNCY XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

190M

Short interest (May 15)

7.6%

Net Short (Jun 03 ): 0.1%

Borrow Fee

0.43%

↓ 7.4%

Available Shares

↑ 5.9%

Price Chart

Company Overview

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001766140

Asset Type: CS

Market Data

Market Cap: $193,041,195

Employees: 22

Status: Active

Short Interest

Current Borrow Fee 0.43%

Range: 0.43% - 0.44%

Available Shares 1M

Range: 1.3M - 1.4M

Recent Changes

Fee Change: ↓ 2.2%

Available Change: ↑ 17.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime